Chris Kassianides

3.0k total citations · 1 hit paper
29 papers, 1.9k citations indexed

About

Chris Kassianides is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Chris Kassianides has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 15 papers in Hepatology and 11 papers in Infectious Diseases. Recurrent topics in Chris Kassianides's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (13 papers) and Hepatitis C virus research (11 papers). Chris Kassianides is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (13 papers) and Hepatitis C virus research (11 papers). Chris Kassianides collaborates with scholars based in South Africa, United States and Zimbabwe. Chris Kassianides's co-authors include Jay H. Hoofnagle, Mauricio Lisker‐Melman, Adrian M. Di Bisceglie, Jeanne G. Waggoner, Steven M. Banks, Zachary Goodman, Linda Murray, Paul Martin, Paul Martin and Michael C. Kew and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Chris Kassianides

29 papers receiving 1.8k citations

Hit Papers

Recombinant Interferon Alfa Therapy for Chronic Hepatitis C 1989 2026 2001 2013 1989 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Kassianides South Africa 16 1.5k 1.4k 303 213 134 29 1.9k
Alexandra L. Gibas United States 9 1.9k 1.3× 1.9k 1.3× 350 1.2× 194 0.9× 87 0.6× 12 2.3k
Liang‐Yen Wang Taiwan 30 2.4k 1.6× 2.3k 1.6× 239 0.8× 196 0.9× 244 1.8× 101 3.0k
Ming‐Yuh Hsieh Taiwan 25 1.9k 1.3× 1.8k 1.3× 206 0.7× 145 0.7× 88 0.7× 72 2.2k
Mauricio Lisker‐Melman United States 23 2.3k 1.5× 2.0k 1.4× 378 1.2× 248 1.2× 278 2.1× 79 2.8k
Jean-Pierre Benhamou France 13 1.5k 1.0× 1.4k 1.0× 165 0.5× 114 0.5× 354 2.6× 18 1.8k
B. Kallinowski Germany 20 1.3k 0.8× 1.1k 0.8× 153 0.5× 129 0.6× 63 0.5× 54 1.6k
Reem Ghalib United States 18 2.7k 1.8× 2.3k 1.6× 251 0.8× 547 2.6× 259 1.9× 47 3.1k
Takeshi Sodeyama Japan 13 1.4k 0.9× 1.3k 0.9× 169 0.6× 123 0.6× 69 0.5× 42 1.7k
L Viladomiu Spain 14 1.6k 1.1× 1.5k 1.1× 73 0.2× 179 0.8× 163 1.2× 25 1.8k
Andrew Campbell United States 15 953 0.6× 967 0.7× 170 0.6× 388 1.8× 72 0.5× 34 1.4k

Countries citing papers authored by Chris Kassianides

Since Specialization
Citations

This map shows the geographic impact of Chris Kassianides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Kassianides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Kassianides more than expected).

Fields of papers citing papers by Chris Kassianides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Kassianides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Kassianides. The network helps show where Chris Kassianides may publish in the future.

Co-authorship network of co-authors of Chris Kassianides

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Kassianides. A scholar is included among the top collaborators of Chris Kassianides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Kassianides. Chris Kassianides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sonderup, Mark, Patrick S. Kamath, Yaw Asante Awuku, et al.. (2024). Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa. ˜The œLancet. Gastroenterology & hepatology. 9(2). 170–184. 5 indexed citations
2.
Katsidzira, Leolin, et al.. (2023). Challenges in the diagnosis and management of IBD: a sub-Saharan African perspective. Therapeutic Advances in Gastroenterology. 16. 1108367962–1108367962. 6 indexed citations
3.
Watermeyer, Gillian, et al.. (2022). Inflammatory bowel disease in sub-Saharan Africa: epidemiology, risk factors, and challenges in diagnosis. ˜The œLancet. Gastroenterology & hepatology. 7(10). 952–961. 15 indexed citations
4.
Jonas, Eduard, M. Bernon, Barbara Robertson, et al.. (2022). Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions. ˜The œLancet. Gastroenterology & hepatology. 7(11). 1049–1060. 13 indexed citations
5.
Watermeyer, Gillian, Yaw Asante Awuku, D. Epstein, et al.. (2022). Challenges in the management of inflammatory bowel disease in sub-Saharan Africa. ˜The œLancet. Gastroenterology & hepatology. 7(10). 962–972. 10 indexed citations
6.
Kassianides, Chris, Geoffrey Dusheiko, Adrian M. Di Bisceglie, & Jay H. Hoofnagle. (2021). Michael Charles Kew - Frontrunner in Hepatology. Journal of Hepatology. 76(3). 754–754. 1 indexed citations
7.
Watermeyer, Gillian, et al.. (2020). Epidemiology of inflammatory bowel disease in sub-Saharan Africa: A review of the current status. South African Medical Journal. 110(10). 1006–1006. 9 indexed citations
8.
Spearman, C Wendy, et al.. (2013). South African guideline for the management of chronic hepatitis B: 2013. South African Medical Journal. 103(5). 335–335. 26 indexed citations
9.
Botha, Jean, et al.. (2010). South African Hepatitis C Management Guidelines 2010 : guidelines. 8(1). 20–25. 4 indexed citations
10.
Richards, Guy A., et al.. (2000). Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects. Critical Care Medicine. 28(1). 240–244. 68 indexed citations
11.
Kew, Michael C. & Chris Kassianides. (1996). HGV: hepatitis G virus or harmless G virus?. The Lancet. 348. S10–S10. 14 indexed citations
12.
Sung, Joseph J.�Y., Francis K.L. Chan, Joseph W. Leung, et al.. (1993). Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. The Lancet. 342(8872). 637–641. 153 indexed citations
13.
Bisceglie, Adrian M. Di, Paul Martin, Mauricio Lisker‐Melman, et al.. (1990). Therapy of chronic delta hepatitis with interferon alfa-2b. Journal of Hepatology. 11. S151–S154. 26 indexed citations
14.
Bisceglie, Adrian M. Di, Vinod K. Rustgi, Chris Kassianides, et al.. (1990). Therapy of Chronic Hepatitis B With Recombinant Human Alpha and Gamma Interferon. Hepatology. 11(2). 266–270. 43 indexed citations
15.
Bisceglie, Adrian M. Di, Paul Martin, Chris Kassianides, et al.. (1989). Recombinant Interferon Alfa Therapy for Chronic Hepatitis C. New England Journal of Medicine. 321(22). 1506–1510. 1054 indexed citations breakdown →
16.
Martin, Paul, Adrian M. Di Bisceglie, Chris Kassianides, Mauricio Lisker‐Melman, & Jay H. Hoofnagle. (1989). Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 97(6). 1559–1561. 177 indexed citations
17.
Kassianides, Chris, Jay H. Hoofnagle, R.H. Miller, et al.. (1989). Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxycytidine. Gastroenterology. 97(5). 1275–1280. 55 indexed citations
18.
Bacher, John, et al.. (1989). A technique for liver biopsy in Pekin ducks.. PubMed. 39(1). 67–8. 2 indexed citations
19.
Hoofnagle, Jay H., et al.. (1988). Management of Post-Transfusion Hepatitis. Transfusion Medicine Reviews. 2(4). 215–220. 5 indexed citations
20.
Kassianides, Chris & Michael C. Kew. (1987). The Clinical Manifestations and Natural History of Hepatocellular Carcinoma. Gastroenterology Clinics of North America. 16(4). 553–562. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026